Explore this gift article from The New York Times. You can read it for free without a subscription. www.nytimes.com/2025/02/13/o...

Important observations by our group @penncancer.bsky.social, led by Dr. Matthew Ho, on non-tuberculous mycobacterial infections in multiple myeloma patients on teclistamab: haematologica.org/article/view...

It was wonderful to get together in-person with our multi-site team working on the LimiTec trial of limited-duration teclistamab therapy for rel/ref #myeloma at #ASH24! Thanks to Leukemia & Lymphoma Society for supporting our trial! clinicaltrials.gov/study/NCT059... @myelomateacher.bsky.social

Not every day a leading US academic health system partners with @costplusdrugs.com, bypassing PBMs, to save drug costs for their patients @pennmedicine.bsky.social + @mcuban.bsky.social www.pennmedicine.org/news/news-re... a 1st-of-its-kind deal

Excited to share our latest work in #MultipleMyeloma! 🧬 We uncovered a six-gene signature predicting response to venetoclax, but also revealed that 1q gain can drive resistance—and how CDK7 inhibitors might reverse it. #MyelomaResearch

Multiple myeloma long-term survivors exhibit sustained immune alterations decades after first-line therapy www.nature.com/articles/s41...

Re-posting this starter pack on multiple myeloma, now updated with a few more accounts. Please share and let me know if I’m missing anyone! go.bsky.app/REknptc

🚨NEW🧪: TET2 regulates early and late transitions in exhausted CD8+ T cell differentiation and limits CAR T cell function - #CARTCell #immunotherapy #TCell #tcellrx #immunology www.science.org/doi/10.1126/...

If you're interested in Stem cell transplant and/or Cellular Therapy this is the list #bmtsm #CARTcells #leusm #mmsm #lymsm #MedSky #TcellRx go.bsky.app/7xxh8WW

#ASH24 Peripheral Residual Disease (PRD) by mass spect and MRD by NGF in NDMM (GEM2017FIT Trial) -79.6% concordance -integration of PRD into routine clinical practice may be beneficial for all elderly pts #mmsm ash.confex.com/ash/2024/web...

Hi all, I created this starter pack of accounts related to multiple myeloma research and clinical care. Please let me know whom I'm missing, and I will update! go.bsky.app/REknptc